Galapagos | GLPG - Market Capitalization

Stock Price
29.56
Daily Change
1.16 4.08%
Monthly
2.14%
Yearly
17.30%
Q1 Forecast
27.85

Galapagos reported EUR1.95B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Biogen USD 27.01B 1.19B Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Incyte USD 22.7B 3.31B Feb/2026
Merck EUR 47.59B 239.13M Sep/2025
Neurocrine Biosciences USD 13.68B 465M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026